Test Drive Our New Site! We have some improvements in the works that we're excited for you to experience. Click here to try our new, faster, mobile friendly beta site. We will be maintaining our current version of the site thru the end of 2024, so you can switch back as our improvements continue.

Bill Information - History

Senate Bill 675; Regular Session 2019-2020

Text

[History]

[Votes]

Sponsors:

BROOKS, BROWNE, HUTCHINSON, STEFANO, K. WARD, KILLION and FOLMER

Printer's No.(PN):

820*

Short Title:

An Act providing for certification of buprenorphine office-based prescribers; limiting the use of buprenorphine; and imposing powers and duties on the Department of Drug and Alcohol Programs.

Actions:

	PN 0820	Referred to HEALTH AND HUMAN SERVICES, May 28, 2019
		Reported as committed, June 4, 2019
		First consideration, June 4, 2019
		Second consideration, June 5, 2019
		Re-referred to APPROPRIATIONS, June 5, 2019
		Re-reported as committed, June 10, 2019
		Third consideration and final passage, June 17, 2019 (41-9)
		In the House
		Referred to HUMAN SERVICES, June 18, 2019

* denotes current Printer's Number

How to Read a Bill About PDF Documents